EBSUJMC PUBLICATION

Title: Evaluation of the Impact of Pharmacovigilance Media Campaign on Public Awareness of Adverse Drugs Reactions among Residents of Ondo State
Author(s): Abubakri, Raman Olaniyan Olaleye, Franklyn Akinola & Ajayi, Olutayo James
Abstract: This study evaluated the impact of pharmacovigilance media campaigns on public awareness of adverse drug reactions (ADRs) among academic staff in tertiary institutions in Ondo State, Nigeria. The study was anchored on Social Marketing Theory and the Health Belief Model. The population comprised 2,926 academic staff across seven tertiary institutions in Ondo State. Using the Taro Yamane formula at a 5% margin of error, a minimum sample size of 352 was determined. To account for possible non-response and incomplete questionnaires, the number of questionnaires administered was increased to 460, representing an additional 30.7%. A multi-stage sampling technique involving clustering, proportional allocation, and purposive selection was adopted. Data were collected using a structured questionnaire administered face-to-face and a semi-structured interview guide. Forty-five academic staff members were purposively selected for in-depth interviews. Quantitative data were analyzed using frequencies, percentages, and mean scores, while interview responses were subjected to thematic analysis. Findings revealed moderate exposure to pharmacovigilance media campaigns and relatively high awareness of adverse drug reactions. However, knowledge of ADR reporting channels was low, indicating a gap between general awareness and actionable reporting knowledge. The campaigns were perceived as moderately effective in increasing awareness but had limited influence on behavioural change. Poor message repetition, inadequate understanding of technical content, limited awareness of reporting procedures, and low public trust in regulatory institutions were identified as major challenges. The study concluded that pharmacovigilance media campaigns have contributed to public awareness of drug safety but remain constrained by communication and structural barriers. It recommended sustained campaign dissemination, simplified messages, clearer information on ADR reporting procedures, stronger stakeholder collaboration, and regular evaluation of campaign effectiveness.
Keywords: Pharmacovigilance, Media Campaign, Adverse Drug Reactions, Public Awareness, NAFDAC
Volume & Issue: Vol: 14, Issue: 1
SEARCH
EDITORIAL TEAM
EDITOR IN-CHIEF

Simon Ugochukwu Nwankwo Ph.D

DEPUTY/MANAGING EDITOR

Agatha Obiageri Orji-Egwu

MANAGING EDITOR

Kenneth Adibe Nwafor, Ph.D

ASSOCIATE EDITORS

Ifeyinwa Nsude, Ph.D

Chike Onwe, Ph.D

Odicha Udeh, Ph.D

EDITORIAL CONSULTANT

Professor Jonathan E. Eliede